The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Rotavirus Vaccines Market Research Report 2025
Synopsis
Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15–34% of severe diarrhea in the developing world and 37–96% of severe diarrhea in the developed world. The vaccines decrease the risk of death among young children due to diarrhea. Immunizing babies decreases rates of disease among older people and those who have not been immunized.
The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. This should be done along with promoting breastfeeding, handwashing, clean water and good sanitation. It is given by mouth and requires two or three doses. It should be given starting around six weeks of age.
The vaccines are safe. This includes their use in people with HIV/AIDS. An earlier vaccine that is no longer used was linked to intussusception, but the current versions are not clearly linked. Due to a potential risk they are not recommended in babies who have had intussusception. The vaccines are made from weakened rotavirus.
The vaccine first became available in the United States in 2006. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.In the United States it is more than US$200. As of 2013 there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries.
The global Rotavirus Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Rotavirus Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rotavirus Vaccines.
Report Scope
The Rotavirus Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rotavirus Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rotavirus Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bharat Biotech
Merck & Co., Inc
GlaxoSmithKline plc
Lanzhou Institute of Biological
Bharat Biotech International Limited
Segment by Type
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
Segment by Application
Adult
Pediatric
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rotavirus Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rotavirus Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15–34% of severe diarrhea in the developing world and 37–96% of severe diarrhea in the developed world. The vaccines decrease the risk of death among young children due to diarrhea. Immunizing babies decreases rates of disease among older people and those who have not been immunized.
The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. This should be done along with promoting breastfeeding, handwashing, clean water and good sanitation. It is given by mouth and requires two or three doses. It should be given starting around six weeks of age.
The vaccines are safe. This includes their use in people with HIV/AIDS. An earlier vaccine that is no longer used was linked to intussusception, but the current versions are not clearly linked. Due to a potential risk they are not recommended in babies who have had intussusception. The vaccines are made from weakened rotavirus.
The vaccine first became available in the United States in 2006. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.In the United States it is more than US$200. As of 2013 there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries.
The global Rotavirus Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Rotavirus Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rotavirus Vaccines.
Report Scope
The Rotavirus Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rotavirus Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rotavirus Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bharat Biotech
Merck & Co., Inc
GlaxoSmithKline plc
Lanzhou Institute of Biological
Bharat Biotech International Limited
Segment by Type
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
Segment by Application
Adult
Pediatric
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rotavirus Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rotavirus Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Rotavirus Vaccines Market Overview
1.1 Product Overview and Scope of Rotavirus Vaccines
1.2 Rotavirus Vaccines Segment by Type
1.2.1 Global Rotavirus Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Rotarix
1.2.3 RotaTeq
1.2.4 Rotavac
1.2.5 Rotavin-M1
1.2.6 Lanzhou lamb
1.2.7 Others
1.3 Rotavirus Vaccines Segment by Application
1.3.1 Global Rotavirus Vaccines Market Value by Application: (2024-2030)
1.3.2 Adult
1.3.3 Pediatric
1.4 Global Rotavirus Vaccines Market Size Estimates and Forecasts
1.4.1 Global Rotavirus Vaccines Revenue 2019-2030
1.4.2 Global Rotavirus Vaccines Sales 2019-2030
1.4.3 Global Rotavirus Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Rotavirus Vaccines Market Competition by Manufacturers
2.1 Global Rotavirus Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Rotavirus Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Rotavirus Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Rotavirus Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rotavirus Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rotavirus Vaccines, Product Type & Application
2.7 Rotavirus Vaccines Market Competitive Situation and Trends
2.7.1 Rotavirus Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rotavirus Vaccines Players Market Share by Revenue
2.7.3 Global Rotavirus Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rotavirus Vaccines Retrospective Market Scenario by Region
3.1 Global Rotavirus Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Rotavirus Vaccines Global Rotavirus Vaccines Sales by Region: 2019-2030
3.2.1 Global Rotavirus Vaccines Sales by Region: 2019-2024
3.2.2 Global Rotavirus Vaccines Sales by Region: 2025-2030
3.3 Global Rotavirus Vaccines Global Rotavirus Vaccines Revenue by Region: 2019-2030
3.3.1 Global Rotavirus Vaccines Revenue by Region: 2019-2024
3.3.2 Global Rotavirus Vaccines Revenue by Region: 2025-2030
3.4 North America Rotavirus Vaccines Market Facts & Figures by Country
3.4.1 North America Rotavirus Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Rotavirus Vaccines Sales by Country (2019-2030)
3.4.3 North America Rotavirus Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Rotavirus Vaccines Market Facts & Figures by Country
3.5.1 Europe Rotavirus Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Rotavirus Vaccines Sales by Country (2019-2030)
3.5.3 Europe Rotavirus Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rotavirus Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Rotavirus Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Rotavirus Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Rotavirus Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Rotavirus Vaccines Market Facts & Figures by Country
3.7.1 Latin America Rotavirus Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Rotavirus Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Rotavirus Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rotavirus Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Rotavirus Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Rotavirus Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Rotavirus Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rotavirus Vaccines Sales by Type (2019-2030)
4.1.1 Global Rotavirus Vaccines Sales by Type (2019-2024)
4.1.2 Global Rotavirus Vaccines Sales by Type (2025-2030)
4.1.3 Global Rotavirus Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Rotavirus Vaccines Revenue by Type (2019-2030)
4.2.1 Global Rotavirus Vaccines Revenue by Type (2019-2024)
4.2.2 Global Rotavirus Vaccines Revenue by Type (2025-2030)
4.2.3 Global Rotavirus Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Rotavirus Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Rotavirus Vaccines Sales by Application (2019-2030)
5.1.1 Global Rotavirus Vaccines Sales by Application (2019-2024)
5.1.2 Global Rotavirus Vaccines Sales by Application (2025-2030)
5.1.3 Global Rotavirus Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Rotavirus Vaccines Revenue by Application (2019-2030)
5.2.1 Global Rotavirus Vaccines Revenue by Application (2019-2024)
5.2.2 Global Rotavirus Vaccines Revenue by Application (2025-2030)
5.2.3 Global Rotavirus Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Rotavirus Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bharat Biotech
6.1.1 Bharat Biotech Corporation Information
6.1.2 Bharat Biotech Description and Business Overview
6.1.3 Bharat Biotech Rotavirus Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bharat Biotech Rotavirus Vaccines Product Portfolio
6.1.5 Bharat Biotech Recent Developments/Updates
6.2 Merck & Co., Inc
6.2.1 Merck & Co., Inc Corporation Information
6.2.2 Merck & Co., Inc Description and Business Overview
6.2.3 Merck & Co., Inc Rotavirus Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck & Co., Inc Rotavirus Vaccines Product Portfolio
6.2.5 Merck & Co., Inc Recent Developments/Updates
6.3 GlaxoSmithKline plc
6.3.1 GlaxoSmithKline plc Corporation Information
6.3.2 GlaxoSmithKline plc Description and Business Overview
6.3.3 GlaxoSmithKline plc Rotavirus Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GlaxoSmithKline plc Rotavirus Vaccines Product Portfolio
6.3.5 GlaxoSmithKline plc Recent Developments/Updates
6.4 Lanzhou Institute of Biological
6.4.1 Lanzhou Institute of Biological Corporation Information
6.4.2 Lanzhou Institute of Biological Description and Business Overview
6.4.3 Lanzhou Institute of Biological Rotavirus Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lanzhou Institute of Biological Rotavirus Vaccines Product Portfolio
6.4.5 Lanzhou Institute of Biological Recent Developments/Updates
6.5 Bharat Biotech International Limited
6.5.1 Bharat Biotech International Limited Corporation Information
6.5.2 Bharat Biotech International Limited Description and Business Overview
6.5.3 Bharat Biotech International Limited Rotavirus Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bharat Biotech International Limited Rotavirus Vaccines Product Portfolio
6.5.5 Bharat Biotech International Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rotavirus Vaccines Industry Chain Analysis
7.2 Rotavirus Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rotavirus Vaccines Production Mode & Process
7.4 Rotavirus Vaccines Sales and Marketing
7.4.1 Rotavirus Vaccines Sales Channels
7.4.2 Rotavirus Vaccines Distributors
7.5 Rotavirus Vaccines Customers
8 Rotavirus Vaccines Market Dynamics
8.1 Rotavirus Vaccines Industry Trends
8.2 Rotavirus Vaccines Market Drivers
8.3 Rotavirus Vaccines Market Challenges
8.4 Rotavirus Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Rotavirus Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Rotavirus Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Rotavirus Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global Rotavirus Vaccines Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Rotavirus Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Rotavirus Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Rotavirus Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Rotavirus Vaccines Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Rotavirus Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Rotavirus Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rotavirus Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Rotavirus Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rotavirus Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rotavirus Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rotavirus Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Rotavirus Vaccines Sales by Region (2019-2024) & (K Units)
Table 18. Global Rotavirus Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global Rotavirus Vaccines Sales by Region (2025-2030) & (K Units)
Table 20. Global Rotavirus Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global Rotavirus Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Rotavirus Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global Rotavirus Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Rotavirus Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America Rotavirus Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Rotavirus Vaccines Sales by Country (2019-2024) & (K Units)
Table 27. North America Rotavirus Vaccines Sales by Country (2025-2030) & (K Units)
Table 28. North America Rotavirus Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Rotavirus Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Rotavirus Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Rotavirus Vaccines Sales by Country (2019-2024) & (K Units)
Table 32. Europe Rotavirus Vaccines Sales by Country (2025-2030) & (K Units)
Table 33. Europe Rotavirus Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Rotavirus Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Rotavirus Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Rotavirus Vaccines Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Rotavirus Vaccines Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Rotavirus Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Rotavirus Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Rotavirus Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Rotavirus Vaccines Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Rotavirus Vaccines Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Rotavirus Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Rotavirus Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Rotavirus Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Rotavirus Vaccines Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Rotavirus Vaccines Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Rotavirus Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Rotavirus Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Rotavirus Vaccines Sales (K Units) by Type (2019-2024)
Table 51. Global Rotavirus Vaccines Sales (K Units) by Type (2025-2030)
Table 52. Global Rotavirus Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global Rotavirus Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global Rotavirus Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Rotavirus Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Rotavirus Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global Rotavirus Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global Rotavirus Vaccines Price (USD/Unit) by Type (2019-2024)
Table 59. Global Rotavirus Vaccines Price (USD/Unit) by Type (2025-2030)
Table 60. Global Rotavirus Vaccines Sales (K Units) by Application (2019-2024)
Table 61. Global Rotavirus Vaccines Sales (K Units) by Application (2025-2030)
Table 62. Global Rotavirus Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global Rotavirus Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global Rotavirus Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Rotavirus Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Rotavirus Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global Rotavirus Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global Rotavirus Vaccines Price (USD/Unit) by Application (2019-2024)
Table 69. Global Rotavirus Vaccines Price (USD/Unit) by Application (2025-2030)
Table 70. Bharat Biotech Corporation Information
Table 71. Bharat Biotech Description and Business Overview
Table 72. Bharat Biotech Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Bharat Biotech Rotavirus Vaccines Product
Table 74. Bharat Biotech Recent Developments/Updates
Table 75. Merck & Co., Inc Corporation Information
Table 76. Merck & Co., Inc Description and Business Overview
Table 77. Merck & Co., Inc Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Merck & Co., Inc Rotavirus Vaccines Product
Table 79. Merck & Co., Inc Recent Developments/Updates
Table 80. GlaxoSmithKline plc Corporation Information
Table 81. GlaxoSmithKline plc Description and Business Overview
Table 82. GlaxoSmithKline plc Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. GlaxoSmithKline plc Rotavirus Vaccines Product
Table 84. GlaxoSmithKline plc Recent Developments/Updates
Table 85. Lanzhou Institute of Biological Corporation Information
Table 86. Lanzhou Institute of Biological Description and Business Overview
Table 87. Lanzhou Institute of Biological Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Lanzhou Institute of Biological Rotavirus Vaccines Product
Table 89. Lanzhou Institute of Biological Recent Developments/Updates
Table 90. Bharat Biotech International Limited Corporation Information
Table 91. Bharat Biotech International Limited Description and Business Overview
Table 92. Bharat Biotech International Limited Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Bharat Biotech International Limited Rotavirus Vaccines Product
Table 94. Bharat Biotech International Limited Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Rotavirus Vaccines Distributors List
Table 98. Rotavirus Vaccines Customers List
Table 99. Rotavirus Vaccines Market Trends
Table 100. Rotavirus Vaccines Market Drivers
Table 101. Rotavirus Vaccines Market Challenges
Table 102. Rotavirus Vaccines Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Rotavirus Vaccines
Figure 2. Global Rotavirus Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Rotavirus Vaccines Market Share by Type in 2023 & 2030
Figure 4. Rotarix Product Picture
Figure 5. RotaTeq Product Picture
Figure 6. Rotavac Product Picture
Figure 7. Rotavin-M1 Product Picture
Figure 8. Lanzhou lamb Product Picture
Figure 9. Others Product Picture
Figure 10. Global Rotavirus Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Rotavirus Vaccines Market Share by Application in 2023 & 2030
Figure 12. Adult
Figure 13. Pediatric
Figure 14. Global Rotavirus Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Rotavirus Vaccines Market Size (2019-2030) & (US$ Million)
Figure 16. Global Rotavirus Vaccines Sales (2019-2030) & (K Units)
Figure 17. Global Rotavirus Vaccines Average Price (USD/Unit) & (2019-2030)
Figure 18. Rotavirus Vaccines Report Years Considered
Figure 19. Rotavirus Vaccines Sales Share by Manufacturers in 2023
Figure 20. Global Rotavirus Vaccines Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Rotavirus Vaccines Players: Market Share by Revenue in 2023
Figure 22. Rotavirus Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Rotavirus Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Rotavirus Vaccines Sales Market Share by Country (2019-2030)
Figure 25. North America Rotavirus Vaccines Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Rotavirus Vaccines Sales Market Share by Country (2019-2030)
Figure 29. Europe Rotavirus Vaccines Revenue Market Share by Country (2019-2030)
Figure 30. Germany Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Rotavirus Vaccines Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Rotavirus Vaccines Revenue Market Share by Region (2019-2030)
Figure 37. China Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Rotavirus Vaccines Sales Market Share by Country (2019-2030)
Figure 48. Latin America Rotavirus Vaccines Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Rotavirus Vaccines Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Rotavirus Vaccines Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. UAE Rotavirus Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Rotavirus Vaccines by Type (2019-2030)
Figure 58. Global Revenue Market Share of Rotavirus Vaccines by Type (2019-2030)
Figure 59. Global Rotavirus Vaccines Price (USD/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of Rotavirus Vaccines by Application (2019-2030)
Figure 61. Global Revenue Market Share of Rotavirus Vaccines by Application (2019-2030)
Figure 62. Global Rotavirus Vaccines Price (USD/Unit) by Application (2019-2030)
Figure 63. Rotavirus Vaccines Value Chain
Figure 64. Rotavirus Vaccines Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
